Sarana Meditama Metropolitan (SAME) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.011x

Based on the latest financial reports, Sarana Meditama Metropolitan (SAME) has a cash flow conversion efficiency ratio of 0.011x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp47.11 Billion ≈ $2.76 Million USD) by net assets (Rp4.19 Trillion ≈ $245.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sarana Meditama Metropolitan (SAME) balance sheet quality index to measure how much of total assets are equity-financed.

Sarana Meditama Metropolitan - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Sarana Meditama Metropolitan's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Sarana Meditama Metropolitan (SAME) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Sarana Meditama Metropolitan Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sarana Meditama Metropolitan ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
WITHSECURE HE:WITH	0.022x
Silver Tiger Metals Inc V:SLVR	-0.008x
Andfjord Salmon AS OL:ANDF	-0.012x
Aprogen Pharmaceuticals Inc KO:003060	-0.024x
Yangzhou Chenhua New Material Co Ltd SHE:300610	-0.012x
Korea Environment Technology Co. LTD KQ:029960	0.041x
American Battery Technology Company Common Stock NASDAQ:ABAT	-0.082x
Alpine Income Property Trust, Inc. NYSE:PINE	0.007x

Annual Cash Flow Conversion Efficiency for Sarana Meditama Metropolitan (2011–2025)

The table below shows the annual cash flow conversion efficiency of Sarana Meditama Metropolitan from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Sarana Meditama Metropolitan market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Rp4.17 Trillion ≈ $244.10 Million	Rp357.02 Billion ≈ $20.92 Million	0.086x	+34.64%
2024-12-31	Rp4.14 Trillion ≈ $242.49 Million	Rp263.42 Billion ≈ $15.44 Million	0.064x	+67.33%
2023-12-31	Rp3.98 Trillion ≈ $233.42 Million	Rp151.55 Billion ≈ $8.88 Million	0.038x	+1481.24%
2022-12-31	Rp3.98 Trillion ≈ $233.39 Million	Rp9.58 Billion ≈ $561.51K	0.002x	-95.80%
2021-12-31	Rp4.43 Trillion ≈ $259.67 Million	Rp253.74 Billion ≈ $14.87 Million	0.057x	+244.24%
2020-12-31	Rp545.82 Billion ≈ $31.98 Million	Rp-21.67 Billion ≈ $-1.27 Million	-0.040x	-120.60%
2019-12-31	Rp977.50 Billion ≈ $57.28 Million	Rp188.40 Billion ≈ $11.04 Million	0.193x	+716.24%
2018-12-31	Rp1.33 Trillion ≈ $77.70 Million	Rp31.31 Billion ≈ $1.83 Million	0.024x	-62.85%
2017-12-31	Rp1.04 Trillion ≈ $61.07 Million	Rp66.26 Billion ≈ $3.88 Million	0.064x	-56.32%
2016-12-31	Rp850.97 Billion ≈ $49.86 Million	Rp123.85 Billion ≈ $7.26 Million	0.146x	+10.60%
2015-12-31	Rp741.18 Billion ≈ $43.43 Million	Rp97.53 Billion ≈ $5.71 Million	0.132x	-77.37%
2014-12-31	Rp191.08 Billion ≈ $11.20 Million	Rp111.12 Billion ≈ $6.51 Million	0.582x	+3.41%
2013-12-31	Rp133.01 Billion ≈ $7.79 Million	Rp74.80 Billion ≈ $4.38 Million	0.562x	-80.36%
2012-12-31	Rp19.22 Billion ≈ $1.13 Million	Rp55.04 Billion ≈ $3.23 Million	2.863x	+137.81%
2011-12-31	Rp-4.05 Billion ≈ $-237.07K	Rp30.64 Billion ≈ $1.80 Million	-7.573x	--

About Sarana Meditama Metropolitan

JK:SAME Indonesia Medical Care Facilities

Market Cap

$301.73 Million

Rp5.15 Trillion IDR

Market Cap Rank

#14781 Global

#174 in Indonesia

Share Price

Rp300.00

Change (1 day)

+0.00%

52-Week Range

Rp286.00 - Rp428.00

All Time High

Rp755.00